BIMINI BIOTECH

BIMINI Biotech is a Leiden-based start-up that is developing innovative first-in-class therapeutics for oncology by uniquely targeting the Wiskott-Aldrich-Syndrome protein... BIMINI's approach is based on proprietary technology that targets the Wiskott-Aldrich-Syndrome Protein (WASp), an actin nucleation related protein expressed exclusively in hematopoietic cells. WASP modulation has shown to deliver a potent anti-cancer effect... BIMINI Biotech combines young ambitious entrepreneurs with scientific key-opinion-leaders and seasoned business experts